Carflieva Carfilzomib Injection 60mg Description:
Carflieva Carfilzomib Injection 60mg is a proteasome inhibitor used in the treatment of multiple myeloma, a type of blood cancer. It works by blocking the action of proteasomes — enzyme complexes that break down proteins within cells. By inhibiting this process, Carfilzomib causes cancer cells to accumulate proteins and die, slowing or stopping the progression of the disease.
Carfilzomib is administered intravenously and is usually used in combination with other anti-cancer medicines.
Uses:
- Treatment of relapsed or refractory multiple myeloma in adult patients who have received one or more prior therapies.
- Often used in combination regimens to improve treatment outcomes.
Side Effects:
- Common side effects may include:
- Fatigue
- Nausea or vomiting
- Diarrhea or constipation
- Low blood cell counts (anemia, thrombocytopenia, neutropenia)
- Shortness of breath
- Fever
- Headache
- High blood pressure
Serious side effects can include:
- Heart problems (e.g., heart failure, heart attack)
- Lung issues (e.g., pulmonary hypertension)
- Liver toxicity
- Infusion-related reactions
- Kidney problems
Patients should be closely monitored by healthcare professionals during treatment.
Dosage:
Your doctor or nurse will give you this Injections. Kindly do not self administer.
Reviews
There are no reviews yet.